Occupation 发表于 2025-3-23 12:58:28

http://reply.papertrans.cn/2/158/15792/15792-11.png

Hot-Flash 发表于 2025-3-23 17:47:20

http://reply.papertrans.cn/2/158/15792/15792-12.png

prostatitis 发表于 2025-3-23 19:33:34

Submitted on: 21 November 2023.
Revised on: 27 December 2023.
Accepted on: 06 February 2024.

___________________JOURNAL OF CHEMOTHERAPY---TAYLOR & FRANCIS LTD

Tailor 发表于 2025-3-24 01:09:38

Submitted on: 13 October 2015.
Revised on: 31 January 2016.
Accepted on: 13 February 2016.

___________________JOURNAL OF CHEMOTHERAPY---TAYLOR & FRANCIS LTD

渗透 发表于 2025-3-24 04:31:24

Submitted on: 26 March 2016.
Revised on: 07 May 2016.
Accepted on: 02 July 2016.

___________________JOURNAL OF CHEMOTHERAPY---TAYLOR & FRANCIS LTD

Dungeon 发表于 2025-3-24 07:40:12

Submitted on: 19 June 2018.
Revised on: 27 July 2018.
Accepted on: 23 September 2018.

___________________JOURNAL OF CHEMOTHERAPY---TAYLOR & FRANCIS LTD

perpetual 发表于 2025-3-24 12:14:29

http://reply.papertrans.cn/2/158/15792/15792-17.png

diabetes 发表于 2025-3-24 17:01:24

Submitted on: 06 August 2006.
Revised on: 26 August 2006.
Accepted on: 07 October 2006.

___________________JOURNAL OF CHEMOTHERAPY---TAYLOR & FRANCIS LTD

想象 发表于 2025-3-24 21:53:14

http://reply.papertrans.cn/2/158/15792/15792-19.png

品牌 发表于 2025-3-25 00:08:17

Submitted on: 16 June 2000.
Revised on: 05 September 2000.
Accepted on: 02 October 2000.

___________________JOURNAL OF CHEMOTHERAPY---TAYLOR & FRANCIS LTD
页: 1 [2] 3 4
查看完整版本: SCIE期刊JOURNAL OF CHEMOTHERAPY 2024/2025影响因子:1.981 (J CHEMOTHERAPY) (1120-009X). (ONCOLOGY)(肿瘤学)Science Citation Index E